Advertisement

Advertisement

pharming

[fahr-ming]

noun

  1. the process of producing medically useful products from genetically modified plants and animals.



pharming

1

/ ˈfɑːmɪŋ /

noun

  1. the practice of rearing or growing genetically-modified animals or plants in order to develop pharmaceutical products

“Collins English Dictionary — Complete & Unabridged” 2012 Digital Edition © William Collins Sons & Co. Ltd. 1979, 1986 © HarperCollins Publishers 1998, 2000, 2003, 2005, 2006, 2007, 2009, 2012

pharming

2

/ ˈfɑːmɪŋ /

noun

  1. the practice of redirecting computer users from legitimate websites to fraudulent ones for the purposes of extracting confidential data

“Collins English Dictionary — Complete & Unabridged” 2012 Digital Edition © William Collins Sons & Co. Ltd. 1979, 1986 © HarperCollins Publishers 1998, 2000, 2003, 2005, 2006, 2007, 2009, 2012
Discover More

Word History and Origins

Origin of pharming1

First recorded in 1990–95; from pharm(aceutical) ( def. ) + -ing 1 ( def. ), modeled on farming ( def. )
Discover More

Word History and Origins

Origin of pharming1

C20: blend of pharmaceutical + farming

Origin of pharming2

C21: from farming in the sense of cultivating and harvesting; computer-hacker slang often replaces f with ph
Discover More

Example Sentences

Examples are provided to illustrate real-world usage of words in context. Any opinions expressed do not reflect the views of Dictionary.com.

Pharming did not respond to questions about its treatment costs, and said it was committed to delivering therapies that make a difference to patients.

Olive-McCoy and her husband were recently flown to Dallas to serve on a patient and caregiver advisory board for Pharming.

Shire, Pharming and CSL Behring make the complex therapies for the genetic condition; the first was approved in the United States in 2008.

The company, which has been selling non-core assets, said it had divested the North American rights to the hereditary angioedema drug, Ruconest, to Netherlands-based Pharming Group NV in deal worth up to $165 million.

A competing approach called molecular "pharming" uses a plant instead of bacteria.

From Reuters

Advertisement

Advertisement

Advertisement

Advertisement


Pharm.D.Pharm.M.